(PATH) Uipath - NYSE
Sector: Technology | Industry: Software - Infrastructure | Exchange: NYSE (USA) | Market Cap: 5.518m USD | Total Return: -15.5% in 12m
Avg Turnover: 473M
EPS Trend: 89.6%
Qual. Beats: 0
Rev. Trend: 97.9%
Qual. Beats: 5
Warnings
Choppy Below Avwap Earnings
Tailwinds
No distinct edge detected
UiPath Inc. (PATH) provides an enterprise-grade automation platform designed to integrate AI agents, robotic process automation (RPA), and API-based workflows. The companys suite includes tools for process orchestration, intelligent document extraction, and centralized governance to coordinate tasks across humans and digital workers. Headquartered in New York, the firm serves global clients in heavily regulated industries such as financial services, healthcare, and manufacturing.
The business operates under a software-as-a-service (SaaS) model, generating revenue primarily through recurring subscriptions for its cloud-based and on-premise automation tools. As a leader in the Systems Software sub-industry, UiPath competes in the rapidly evolving Intelligent Automation market, which shifts traditional RPA toward generative AI-driven agentic workflows. To better understand these competitive dynamics and valuation metrics, consider reviewing the detailed financial breakdowns on ValueRay.
- Transition to agentic AI workflows shifts revenue from legacy RPA to high-margin software
- Subscription ARR growth remains primary metric for valuation and long-term free cash flow
- Competitive pressure from Microsoft Power Automate impacts enterprise pricing and market share expansion
- Global enterprise IT spending cycles dictate pace of large-scale digital transformation contracts
| Net Income: 327.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 1.08 > 1.0 |
| NWC/Revenue: 59.80% < 20% (prev 96.05%; Δ -36.25% < -1%) |
| CFO/TA 0.13 > 3% & CFO 384.1m > Net Income 327.4m |
| Net Debt (-1.15b) to EBITDA (125.9m): -9.16 < 3 |
| Current Ratio: 2.20 > 1.5 & < 3 |
| Outstanding Shares: last quarter (527.8m) vs 12m ago -3.76% < -2% |
| Gross Margin: 82.96% > 18% (prev 82.40%; Δ 0.57% > 0.5%) |
| Asset Turnover: 60.27% > 50% (prev 54.88%; Δ 5.40% > 0%) |
| Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM) |
| A: 0.34 (Total Current Assets 1.83b - Total Current Liabilities 831.7m) / Total Assets 2.90b |
| B: -0.58 (Retained Earnings -1.68b / Total Assets 2.90b) |
| C: 0.04 (EBIT TTM 104.7m / Avg Total Assets 2.77b) |
| D: 1.90 (Book Value of Equity 1.90b / Total Liabilities 1.00b) |
| Altman-Z'' = 2.62 = A |
| DSRI: 0.96 (Receivables 410.2m/371.2m, Revenue 1.67b/1.45b) |
| GMI: 0.99 (GM 82.40% / 82.96%) |
| AQI: 2.05 (AQ_t 0.33 / AQ_t-1 0.16) |
| SGI: 1.15 (Revenue 1.67b / 1.45b) |
| TATA: -0.02 (NI 327.4m - CFO 384.1m) / TA 2.90b) |
| Beneish M = -2.34 (Cap -4..+1) = BBB |
As of June 15, 2026, the stock is trading at USD 10.55 with a total of 40,781,575 shares traded.
Over the past week, the price has changed by -6.14%,
over one month by +9.10%,
over three months by -8.82% and
over the past year by -15.46%.
Uipath has received a consensus analysts rating of 3.17. Therefore, it is recommended to hold PATH.
- StrongBuy: 3
- Buy: 1
- Hold: 18
- Sell: 1
- StrongSell: 1
| Analysts Target Price | 13.3 | 26.2% |
P/E Trailing = 17.75
P/E Forward = 13.4048
P/S = 3.2996
P/B = 2.8997
P/EG = 0.3827
Revenue TTM = 1.67b USD
EBIT TTM = 104.7m USD
EBITDA TTM = 125.9m USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = 155.0m USD (from shortLongTermDebtTotal, last quarter) + Leases 83.0m
Net Debt = -1.15b USD (calculated: Debt 155.0m - CCE 1.31b)
Enterprise Value = 4.36b USD (5.52b + Debt 155.0m - CCE 1.31b)
Interest Coverage Ratio = unknown (Ebit TTM 104.7m / Interest Expense TTM 0.0)
EV/FCF = 11.63x (Enterprise Value 4.36b / FCF TTM 375.2m)
FCF Yield = 8.60% (FCF TTM 375.2m / Enterprise Value 4.36b)
FCF Margin = 22.44% (FCF TTM 375.2m / Revenue TTM 1.67b)
Net Margin = 19.58% (Net Income TTM 327.4m / Revenue TTM 1.67b)
Gross Margin = 82.96% ((Revenue TTM 1.67b - Cost of Revenue TTM 284.9m) / Revenue TTM)
Gross Margin QoQ = 81.13% (prev 84.88%)
Tobins Q-Ratio = 1.50 (Enterprise Value 4.36b / Total Assets 2.90b)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 155.0m)
Taxrate = 45.02% (18.4m / 41.0m)
NOPAT = 57.6m (EBIT 104.7m * (1 - 45.02%))
Current Ratio = 2.20 (Total Current Assets 1.83b / Total Current Liabilities 831.7m)
Debt / Equity = 0.08 (Debt 155.0m / totalStockholderEquity, last quarter 1.90b)
Debt / EBITDA = -9.16 (Net Debt -1.15b / EBITDA 125.9m)
Debt / FCF = -3.07 (Net Debt -1.15b / FCF TTM 375.2m)
Total Stockholder Equity = 1.89b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.80% (Net Income 327.4m / Total Assets 2.90b)
RoE = 17.29% (Net Income TTM 327.4m / Total Stockholder Equity 1.89b)
RoCE = 5.05% (EBIT 104.7m / Capital Employed (Total Assets 2.90b - Current Liab 831.7m))
RoIC = 2.89% (NOPAT 57.6m / Invested Capital 1.99b)
WACC = 11.12% (E(5.52b)/V(5.67b) * Re(11.43%) + D(155.0m)/V(5.67b) * Rd(0.0%) * (1-Tc(0.45)))
Discount Rate = 11.43% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -86.67 | Cagr: -4.34%
[DCF] Terminal Value 69.56% ; FCFF base≈350.3m ; Y1≈401.6m ; Y5≈591.1m
[DCF] Fair Price = 15.70 (EV 5.97b - Net Debt -1.15b = Equity 7.12b / Shares 453.4m; r=11.12% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 89.59 | EPS CAGR: 20.34% | SUE: -0.18 | # QB: 0
Revenue Correlation: 97.93 | Revenue CAGR: 12.72% | SUE: 2.43 | # QB: 5
EPS current Quarter (2026-07-31): EPS=0.15 | Chg30d=-1.93% | Revisions=+26% | Analysts=19
EPS next Quarter (2026-10-31): EPS=0.19 | Chg30d=-0.64% | Revisions=+18% | Analysts=19
EPS current Year (2027-01-31): EPS=0.79 | Chg30d=-1.83% | Revisions=+33% | GrowthEPS=+9.0% | GrowthRev=+10.4%
EPS next Year (2028-01-31): EPS=0.91 | Chg30d=+1.18% | Revisions=+57% | GrowthEPS=+15.5% | GrowthRev=+8.4%
[Analyst] Revisions Ratio: +57%